legislation: 108-s-2944
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| bill_id | congress | bill_type | bill_number | title | policy_area | introduced_date | latest_action_date | latest_action_text | origin_chamber | sponsor_name | sponsor_state | sponsor_party | sponsor_bioguide_id | cosponsor_count | summary_text | update_date | url |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 108-s-2944 | 108 | s | 2944 | A bill to provide that no funds may be expended by the United States Trade Representative to negotiate data exclusivity provisions for certain pharmaceutical products. | Foreign Trade and International Finance | 2004-10-08 | 2004-10-08 | Read twice and referred to the Committee on Finance. (text of measure as introduced: CR S10848) | Senate | Sen. Wyden, Ron [D-OR] | OR | D | W000779 | 0 | Prohibits funds appropriated or otherwise obligated to the U.S. Trade Representative from being expended to negotiate data exclusivity provisions with any country with respect to public health pharmaceutical products or to require actions of another country which interfere with a country's access to such products. | 2023-01-14T22:48:35Z |